| Not Yet Recruiting | A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease (DED) | Phase 2 | 2025-08-01 |
| Unknown | Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Dia Dry Eye Disease | Phase 3 | 2023-12-29 |
| Completed | Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye Dry Eye Disease | Phase 2 | 2020-02-14 |
| Completed | Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjuncti Allergic Conjunctivitis | Phase 2 | 2017-10-13 |
| Terminated | Visual Function Tests in Age-related Macular Degeneration Age Related Macular Degeneration | — | 2017-09-21 |
| Completed | Safety and Efficacy of TOP1630 for Dry Eye Syndrome Dry Eye Syndrome | Phase 2 | 2017-02-20 |
| Completed | Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels Age Factor, Age-related Macular Degeneration | — | 2016-08-23 |
| Completed | Food Allergy Diagnostic Test Response to Previous Oral Challenge Response Food Hypersensitivity | N/A | 2016-05-01 |
| Completed | Food Allergy Challenge Diagnostic Study Food Hypersensitivity | — | 2016-03-01 |
| Completed | Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Roht Dry Eye | Phase 4 | 2015-12-01 |
| Completed | A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Micro Allergic Conjunctivitis | Phase 4 | 2014-12-01 |
| Withdrawn | A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses Contact Lens Complication | N/A | 2014-08-01 |
| Completed | Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen Allergic Rhinitis | — | 2013-08-01 |
| Completed | Mucin Levels in Dry Eye and Normal Populations Dry Eye | — | 2013-05-01 |
| Completed | Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model Chronic Allergic Conjunctivitis | Phase 4 | 2012-11-01 |
| Completed | Effect of Controlled Adverse Environment (CAE) on Tear Film Stability Keratoconjunctivitis Sicca | — | 2012-02-01 |
| Completed | Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Allergic Conjunctivitis | Phase 4 | 2012-01-01 |
| Completed | An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Plac Allergic Rhinitis, Allergic Conjunctivitis | Phase 4 | 2011-09-01 |
| Completed | A Single-Center Pilot Study to Assess Macular Function Macular Degeneration | — | 2010-09-01 |
| Completed | Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC) Allergic Rhinoconjunctivitis | — | 2009-09-01 |
| Withdrawn | Efficacy Study of Ketorolac and HPMC to Treat Dry Eye Dry Eye | Phase 2 | 2009-03-01 |
| Completed | A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in Allergic Rhinoconjunctivitis | — | 2008-12-01 |
| Completed | A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season Allergic Conjunctivitis | — | 2008-08-01 |
| Completed | Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction Meibomian Gland Dysfunction | Phase 2 | 2008-07-01 |
| Completed | Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Allergic Conjunctivitis | Phase 4 | 2008-05-01 |
| Withdrawn | An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatad Allergic Rhinitis | Phase 4 | — |